Home › Trial NCT01050829
Gadobutrol Magnevist-controlled Body Study
- Trial IDNCT01050829
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorBayer
- Enrollment370
- Start date2010-01
- ConditionsMagnetic Resonance Imaging
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.